LKFT LKFT
Company Profile ↓Company Overview
LKFT (LKFT) is a publicly traded company listed on with a market capitalization of $1.72B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Return on capital employed stands at 15.4%.
Revenue has grown at a 66.4% CAGR over the past five years.
Trades at an undemanding P/E of 5.4.
Maintains a net profit margin of 28.8%.
Carries low leverage with a debt-to-equity ratio of 0.21.
Recent Developments
- Dec 2025 Revenue of $1.11B (+303.5% YoY); net profit $320.88M.
- Trailing 12 Months Year-on-year growth — revenue +303.5%, earnings +333.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 66.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 66.44% |
| 1 Year: | 303.50% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | 333.15% |
Stock Price Performance
| 1 Year: | -21.89% |
| 6 Months: | -24.62% |
| 3 Months: | -8.14% |
| 1 Month: | -14.72% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)24.97 · Oversold
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 28.8%.
- Compounding revenue at 66.4% over 5 years.
CONS
- Trading 30.7% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
- RSI at 25 suggests oversold conditions.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 74.98M | 65.29M | 71.16M | 900.82M | 6.48M |
| Cost of Revenue | - | 13.73M | 4.71M | 10.85M | 455.00K | 4.80M |
| Gross Profit | - | 61.25M | 60.58M | 60.31M | 900.37M | 1.68M |
| Operating Expenses | - | 219.96M | 117.61M | 101.99M | 141.57M | 65.39M |
| Operating Income | - | -158.71M | -57.03M | -41.67M | 758.80M | -63.70M |
| EBITDA | - | -158.71M | -101.12M | 2.42M | 560.50M | -63.70M |
| Interest Expense | 97.00K | - | - | - | - | - |
| Pretax Income | - | -156.37M | -104.42M | -221.49M | 783.15M | 13.96M |
| Tax Provision | - | -1.81M | 26.00K | -17.50M | 666.00K | 70.00K |
| Net Income | - | -153.40M | -105.75M | -202.11M | 782.15M | 14.49M |
| Diluted EPS | - | -2.33 | - | - | - | 0.22 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 241.25M | 239.72M | 275.65M | 1.11B |
| Cost of Revenue | 0 | 0 | 34.86M | 29.74M |
| Gross Profit | 241.25M | 239.72M | 240.79M | 1.08B |
| Operating Expenses | 372.31M | 327.99M | 429.12M | 581.12M |
| Operating Income | -131.06M | -88.26M | -188.34M | 501.39M |
| EBITDA | 3.87M | 51.04M | 43.33M | 358.96M |
| Interest Expense | 9.15M | 1.77M | 911.00K | 2.22M |
| Pretax Income | -70.85M | 5.62M | -3.08M | 300.87M |
| Tax Provision | 572.00K | 9.61M | -1.80M | -18.62M |
| Net Income | -217.99M | 211.70M | 74.08M | 320.88M |
| Diluted EPS | -3.32 | 3.21 | 1.12 | 4.87 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 4.73B | 4.36B | 4.14B | 3.41B |
| Current Assets | - | 4.24B | 3.86B | 3.34B | 3.08B |
| Cash & Equivalents | - | 508.12M | 166.80M | 64.24M | 87.87M |
| Inventory | - | 52.92M | 73.98M | 51.19M | 22.49M |
| Receivables | - | 28.19M | 17.49M | 32.47M | 9.57M |
| Total Liabilities | - | 2.21B | 1.56B | 1.24B | 170.65M |
| Current Liabilities | - | 522.54M | 428.22M | 335.08M | 152.86M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 21.90M | 9.60M | 11.72M | 6.92M |
| Total Equity | - | 2.53B | 2.80B | 2.90B | 3.24B |
| Shares Outstanding | - | 65.84M | 65.90M | 65.90M | 65.90M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -500.54M | -405.97M | -320.03M | -257.46M |
| Investing Cash Flow | - | -1.25B | 71.19M | 220.60M | 288.81M |
| Financing Cash Flow | - | -1.49M | -5.00M | -4.92M | -3.27M |
| Capital Expenditure | - | -36.95M | -19.27M | -82.11M | -13.86M |
| Free Cash Flow | - | -537.49M | -425.24M | -402.14M | -271.31M |
| Net Change in Cash | - | -1.75B | -339.79M | -104.35M | 28.09M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | 100.0% | 100.0% | 87.4% | 97.3% |
| Operating Margin % | -54.3% | -36.8% | -68.3% | 45.1% |
| Net Margin % | -90.4% | 88.3% | 26.9% | 28.9% |
| ROE % | -8.6% | 7.6% | 2.6% | 9.9% |
| ROCE % | -3.1% | -2.2% | -5.0% | 15.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for LKFT
Get on line because Disney parks drove Q3 growth, earnings lift stock - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPZm01MUhLZVlIellQMkM0LUNHTG4zS1E1U1FoZW4xMTBQNTZaS21TRDFhRVdBREY0X2JIaThQeDI2dFVRdjVMdFl4bV9NYVo1OHU1RzNYVEwtYWUwcmd6My1XdTJMbWZFNEgwcFdRNUdyVjF5SERjbUJuaExQOUFTSGNxbTM4cVRINk5hV3…
Lakefront Biotherapeutics NV (XBRU:LKFT) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5heFRhMVRCbHBuWWp4UmRCeDJXcjIwTWR0YlVtT2dkejhDdlktakM0Zkp5anhVblUwWnpCVlNRX2h5MjEtSmxKbkYzcGpETjczQ0VPSk1CT3hnLWxGa2hJ?oc=5" target="_blank">Lakefront Biotherapeutics NV (XBRU:LKFT…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTFA0c2pGQUlldkN3bGpibW9BQjRUM2lEaXA0VUM2ZmVTeDNCdVUydnBWQmdMbEoxSTh5NmJRcGNHSVB6SDhKVGN4WjVKZ092MjVP?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Lakefront Biotherapeutics (LKFT) repurchases 95,670 shares in July 2026 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxNYVhleV9USU9sZVhDZWhfWGlfcThHN2U1QkpMQXRVS25SWHpSdTdhRFc5d3lUd0lPX2pTdkdwVlBSMkk2Q3R6ZERYVkh5dnNRenNicTdMbWlBbmJpR09nTTdiOHBMZlNTTFdBWFYxUkY5aDRKaEFLdmNYUElYX2oya2hka1hhU19qY0h5Nz…
Lakefront Biotherapeutics (ENXTAM:LKFT) Stock After Recent Gains Still A Recovery Opportunity? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOUTV2Xy1oVUI4S1M5ckxKcktULUg2QzFITHZCUVF3dnlfN0k3TzIxRl81cDZoUThMb3BhSXYzZHRNNDRubzBxVWpSbXVGMGpVd0pGM3A5Q0ZmMzJJNWp4b2k5elUwc2E3MUNmcFJVLWJBLVRfdVpNYVdFWmthQ21YLW9GcVR4bFY4YnRpMX…
Lakefront draws Equal Weight rating at Morgan Stanley (LKFT) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPTThhT01fZC12Mmw2cDE4SmlIMFRBbF9ibTc3Um1uNlVLTFhUZWp4SjdSQUNKQ29NWVJzS1poSHJsWEFkNHV5MEQ2OUpFbWNMYi1hMDk2NGlEdlRoMTRCSlRIbXkzSDZBNkY1dmlSU3B4eEtIcmFhalNjNW9YUlVELWdTTEtNdVpPUllNb0…
LKFT — Frequently Asked Questions
What is the current share price of LKFT?
As of 2026-08-05 17:25 PDT, LKFT trades at $26.08 on NASDAQ/NYSE. Its 52-week range is $26.08 to $37.62.
What is the market capitalisation of LKFT?
LKFT has a market capitalisation of $1.72B on NASDAQ/NYSE.
What is the P/E ratio of LKFT?
LKFT trades at a trailing price-to-earnings (P/E) ratio of 5.36. Its price-to-book (P/B) ratio is 0.53.
What is the return on equity (ROE) of LKFT?
LKFT has a return on equity (ROE) of 9.92%. Its return on capital employed (ROCE) is 15.41%.
Is LKFT a good stock to buy?
This page provides a data-driven analysis of LKFT, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.